Form 4: Zoetis Director Paul Bisaro Reports RSU Vesting

Zoetis Inc. Director Paul Bisaro reported the vesting of 1,936 restricted stock units on February 18, 2026, and 1,619.3325 restricted stock units on February 19, 2025.

Summary

• Director Paul Bisaro reported the vesting of 1,936 Restricted Stock Units (RSUs) on February 18, 2026.
• These 1,936 RSUs were granted on February 18, 2025, and each represents a contingent right to receive one share of Zoetis Inc. common stock.
• An additional 1,619.3325 RSUs, granted on February 19, 2024, vested on February 19, 2025.
• All RSUs were granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan and include dividend equivalent units.
• The vesting is subject to continued service through the vesting date, with provisions for earlier vesting upon certain specific events.
• The transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive event due to increased insider ownership, though tempered by the late reporting of a prior vesting event.

Positives

• Increased direct beneficial ownership of Zoetis Inc. common stock equivalents for Director Paul Bisaro, aligning his interests with shareholders.
• The transactions were conducted under a Rule 10b5-1(c) plan, indicating pre-planned equity management.

Negatives

• The vesting of 1,619.3325 RSUs on February 19, 2025, was reported significantly late, as the Form 4 was filed on February 19, 2026.

Future Outlook

The vesting of 1,936 Restricted Stock Units on February 18, 2026, indicates a future increase in Director Paul Bisaro's direct beneficial ownership of Zoetis common stock, subject to his continued service.

Management Comments

• Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.
• Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
• Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Industry Context

StockSavvy.ai notes that equity compensation, particularly through Restricted Stock Units, is a standard practice across industries, including the animal health sector, to align executive and director incentives with long-term shareholder value. The reporting of such transactions is a routine compliance requirement for insiders.

Comparison to Industry Standards

• Equity compensation for directors, such as the RSU grants to Paul Bisaro, is a common practice in publicly traded companies, including peers in the pharmaceutical and animal health sectors like Elanco Animal Health (ELAN) or IDEXX Laboratories (IDXX).
• The specific number of units granted would typically be benchmarked against peer compensation packages, considering company size, performance, and director responsibilities, though this filing does not provide such comparative data.

Stakeholder Impact

• Shareholders: Increased alignment of Director Paul Bisaro's interests with shareholders through direct equity ownership.

Next Steps

• Continued service of Director Paul Bisaro through the vesting date of February 18, 2026, for the remaining 1,936 RSUs.
• Settlement of the vested RSUs into shares of Zoetis Inc. common stock.

Key Dates

Recommendation

The filing reports routine equity compensation vesting for a director, which is an expected part of corporate governance and compensation. While it increases insider ownership, it does not present new information that would fundamentally alter the investment thesis for Zoetis Inc. The late reporting of a prior vesting event is a compliance issue but not material enough to warrant a change in recommendation based solely on this filing.

Keywords

Zoetis, ZTS, Paul Bisaro, Restricted Stock Units, RSU, Insider Transaction, SEC Form 4, Equity Compensation, Director Compensation, 10b5-1 Plan